STKE Fundamental Analysis - SOL STRATEGIES INC

Fundamental Rating

Overall STKE gets a fundamental rating of 2 out of 10. We evaluated STKE against 238 industry peers in the Capital Markets industry. Both the profitability and financial health of STKE have multiple concerns. STKE is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

STKE had negative earnings in the past year.

In the past year STKE has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: STKE reported negative net income in multiple years.

STKE had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.64%, STKE is doing worse than 76.89% of the companies in the same industry.

Looking at the Return On Equity, with a value of -4.25%, STKE is doing worse than 75.21% of the companies in the same industry.

With a Return On Invested Capital value of 0.57%, STKE is not doing good in the industry: 70.59% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-2.64%
ROE	-4.25%
ROIC	0.57%

ROA(3y)-4.16%

ROA(5y)-3.71%

ROE(3y)-3.7%

ROE(5y)-3.54%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of STKE (5.82%) is worse than 69.33% of its industry peers.

STKE does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	5.82%
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for STKE has been reduced compared to 1 year ago.

STKE has more shares outstanding than it did 5 years ago.

STKE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that STKE is in the distress zone and has some risk of bankruptcy.

STKE has a Altman-Z score (0.85) which is comparable to the rest of the industry.

A Debt/Equity ratio of 0.54 indicates that STKE is somewhat dependend on debt financing.

STKE has a Debt to Equity ratio of 0.54. This is in the better half of the industry: STKE outperforms 63.45% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Altman-Z	0.85

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.17 indicates that STKE may have some problems paying its short term obligations.

STKE has a worse Current ratio (0.17) than 90.34% of its industry peers.

STKE has a Quick Ratio of 0.17. This is a bad value and indicates that STKE is not financially healthy enough and could expect problems in meeting its short term obligations.

STKE has a Quick ratio of 0.17. This is amonst the worse of the industry: STKE underperforms 90.34% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.17
Quick Ratio	0.17

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for STKE have decreased strongly by -465.40% in the last year.

STKE shows a strong growth in Revenue. In the last year, the Revenue has grown by 787.33%.

Measured over the past years, STKE shows a very strong growth in Revenue. The Revenue has been growing by 196.62% on average per year.

EPS 1Y (TTM)-465.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-468.86%

Revenue 1Y (TTM)787.33%

Revenue growth 3Y196.62%

Revenue growth 5YN/A

Sales Q2Q%324.76%

3.2 Future

Based on estimates for the next years, STKE will show a very negative growth in Earnings Per Share. The EPS will decrease by -116.68% on average per year.

STKE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 67.09% yearly.

EPS Next Y-381.56%

EPS Next 2Y-116.68%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year100%

Revenue Next 2Y67.09%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STKE. In the last year negative earnings were reported.

Also next year STKE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

STKE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. STKE is cheaper than 74.79% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	17.95

4.3 Compensation for Growth

A cheap valuation may be justified as STKE's earnings are expected to decrease with -116.68% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-116.68%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

STKE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SOL STRATEGIES INC

NASDAQ:STKE (12/4/2025, 8:00:00 PM)

After market: 2.6 -0.09 (-3.35%)

2.69

+0.04 (+1.51%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)08-26 2025-08-26

Earnings (Next)01-26 2026-01-26

Inst Owners0.67%

Inst Owner ChangeN/A

Ins Owners17.11%

Ins Owner ChangeN/A

Market Cap74.08M

Revenue(TTM)19.56M

Net Income(TTM)-4.34M

Analysts82.86

Price Target21.09 (684.01%)

Short Float %2.66%

Short Ratio1.19

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0.21%

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	5.29
P/FCF	N/A
P/OCF	N/A
P/B	1.01
P/tB	3.22
EV/EBITDA	17.95

EPS(TTM)-0.13

EYN/A

EPS(NY)-0.49

Fwd EYN/A

FCF(TTM)-0.43

FCFYN/A

OCF(TTM)-0.22

OCFYN/A

SpS0.51

BVpS2.65

TBVpS0.84

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.64%
ROE	-4.25%
ROCE	0.79%
ROIC	0.57%
ROICexc	0.58%
ROICexgc	1.05%
OM	5.82%
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-4.16%

ROA(5y)-3.71%

ROE(3y)-3.7%

ROE(5y)-3.54%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score1

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Debt/EBITDA	7.08
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.17
Quick Ratio	0.17
Altman-Z	0.85

F-Score1

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-465.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-468.86%

EPS Next Y-381.56%

EPS Next 2Y-116.68%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)787.33%

Revenue growth 3Y196.62%

Revenue growth 5YN/A

Sales Q2Q%324.76%

Revenue Next Year100%

Revenue Next 2Y67.09%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y14.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1629.57%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-818.64%

OCF growth 3YN/A

OCF growth 5YN/A

SOL STRATEGIES INC / STKE FAQ

What is the ChartMill fundamental rating of SOL STRATEGIES INC (STKE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to STKE.

Can you provide the valuation status for SOL STRATEGIES INC?

ChartMill assigns a valuation rating of 1 / 10 to SOL STRATEGIES INC (STKE). This can be considered as Overvalued.

How profitable is SOL STRATEGIES INC (STKE) stock?

SOL STRATEGIES INC (STKE) has a profitability rating of 0 / 10.

Can you provide the dividend sustainability for STKE stock?

The dividend rating of SOL STRATEGIES INC (STKE) is 0 / 10 and the dividend payout ratio is 0%.

SOL STRATEGIES INC (STKE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SOL STRATEGIES INC / STKE FAQ

What is the ChartMill fundamental rating of SOL STRATEGIES INC (STKE) stock?

Can you provide the valuation status for SOL STRATEGIES INC?

How profitable is SOL STRATEGIES INC (STKE) stock?

Can you provide the dividend sustainability for STKE stock?